Abstract:Concerning the recent articles published in your journal on multifunctional nanosystem for cancer chemotherapy.1 It should be an admirable approach to kill cancer cells, with the least side effects on normal tissues and cells. During the past few decades, various chemotherapeutic agents, such as cyclophosphamide, fluorouracil, platinum-based compounds, anthracycline, hydroxycamptothecin and paclitaxel, have been designed and proved to be effective toward cancer cells. However, regrettably, these drugs are non-targeted to cancer, and thus serious side effects to normal cells or tissues are unavoidable.2 Therefore, new drugs with selective cytotoxicity become an important research focus in cancer chemotherapy. Another obstacle for chemotherapy is the multidrug resistance. Actually, several targeted drugs such as RTK inhibitors, FTase inhibitors, tumor angiogenesis inhibitors, campath, avastin and erbitux, have been commercialized and widely used clinically.3 However, drug resistance seriously limited their anticancer efficacy. Nanotechnology-based approaches are anticipated to provide a new breakthrough for targeting cancer cells and bypassing their multidrug resistance.4 Zhang et al1 have developed two biodegradable novel drug delivery systems: poly(ethylene glycol)-modified docetaxel-lipid-based-nanosuspensions (pLNS), to increase the cycle time of the drugs within the body and enhance the accumulation of the drugs at the tumor sites, and targeted docetaxel-lipid-based-nanosuspensions (tLNS) using folate as the targeting ligand, which could target cancer cells overexpressing folate receptor (FR). In vitro cytotoxicity was employed to evaluate the effects on human hepatocellular liver carcinoma HepG2 (FR−) and B16 (FR+) cells and the results showed that the cytotoxicity of tLNS against B16 cell lines was superior to pLNS, while no significant difference was observed for HepG2 cells. Moreover, in vivo anticancer efficacy evaluation showed that tLNS exhibited higher efficacy in reducing the tumor volume compared with pLNS. These results reveal the application potential of tLNS to enhance the accumulation of the drugs in cancerous tissues and cells. Similarly, Du et al5 entrapped RGD peptide with poly(ethylene glycol)-modified stearic acid-grafted chitosan (PEG-CS-SA) nanomicelles via chemical reaction in the presence of N,N′-disuccinimidyl carbonate. Moveover, doxorubicin (DOX) was chosen as a model anticancer drug to investigate the drug entrapment efficiency, in vitro drug-release profile and anticancer activities of drug-loaded RGD-PEG-CS- SA micelles in cells overexpressing integrins and integrin-deficient cells. Their results indicated that RGD-modified micelles could significantly increase the intracellular DOX concentration and induce apoptosis in integrin-overexpressing BEL-7402 human hepatocellular carcinoma cells, but not in Hela human epithelial carcinoma cells. These results indicate that surface modification of PEG-CS-SA nanomicelles with RGD could be effective in selectively killing integrin-overexpressing tumor cells and minimizing the side effects on normal cells. Nanosystem functionalized with carbohydrate, such as polysaccharides, a class of biopolymers naturally originated from plants or animals,6 could specifically interact with lectins that have been found overexpressed in the surface of cancer cells and malignant tissues.7 Therefore, we explored a simple method for functionalization of selenium nanoparticles (SeNPs) to enhance the cellular uptake and selective anticancer activity by surface decoration of Spirulina polysaccharides (SPS).8 The underlying molecular mechanisms were also investigated and the results revealed that SPS effectively increased the apoptosis-inducing activity of SeNPs. Moreover, we also demonstrated another strategy for preparation SeNPs through direct nanolization of gray Se by dissolving in PEG. The PEG-functionalized SeNPs exhibited higher potency toward doxorubicin-resistant hepatocellular carcinoma cells.9 Our results suggest that the strategy to use PEG200 as a surface decorator could be a highly efficient way to enhance the anticancer efficacy of nanomaterials. In the recent relevant studies, Zhang et al10–12 explored the cell functions (including adhesion, proliferation, apoptosis and vascular endothelial growth factor (VEGF) secretion) decreasing activity of poly(lactic-co-glycolic acid) (PLGA) nanotopographies with different size and surface property to lung epithelial carcinoma cells and breast adenocarcinoma cells. The nanomaterials could be used to inhibit the growth, proliferation and angiogenesis of tumors, which open up new vistas for majorizating the surface and size of nanomedicine with antitumor properties. As a novel idea of drug design in the future, nanomedicine shows great potential in cancer chemotherapy. For instance, liposomes, nanomicelles, PLGA nanoparticles and carbon nanotubes, are now used as drug delivery carriers to improve the solubility, bioavailability and controled release of anticancer drugs. Moreover, nanocarriers provide a potential to conjugate ligands that target to different kinds of cancer cells or tissues. As a developing interdisciplinary, there are still some problems to be solved in cancer nanotechnology, such as the toxicity and safety, which require special consideration in future works.

Chinese Medicine Single-Walled Carbon Nanotube Targeting Compound for Antitumor Therapy: a Feasible Way?

Drug delivery with carbon nanotubes for in vivo cancer treatment

Optimization of Surface Chemistry on Single-Walled Carbon Nanotubes for in Vivo Photothermal Ablation of Tumors

Traditional Chinese medicine-combination therapies utilizing nanotechnology-based targeted delivery systems: a new strategy for antitumor treatment

Enhancement of curcumin antitumor efficacy and further photothermal ablation of tumor growth by single-walled carbon nanotubes delivery system in vivo

Nanoparticle Delivery of Active Traditional Chinese Medicine Ingredients: A New Strategy for the Treatment of Liver Cancer

Multi-functionalized single-walled carbon nanotubes as delivery carriers: promote the targeting uptake and antitumor efficacy of doxorubicin

Targeting Nanomaterials: Future Drugs for Cancer Chemotherapy

Enhanced Antitumor Efficacy of Novel Biomimetic Platelet Membrane-Coated Tetrandrine Nanoparticles in Nonsmall Cell Lung Cancer

Self-assembled nanodrug delivery systems for anti-cancer drugs from traditional Chinese medicine

Targeted therapeutic nanotubes influence the viscoelasticity of cancer cells to overcome drug resistance

Nanotechnological advances in cancer: therapy a comprehensive review of carbon nanotube applications

Dual covalent functionalization of single-walled carbon nanotubes for effective targeted cancer therapy

Synergistic Photothermal Therapy and Chemotherapy Enabled by Tumor Microenvironment-Responsive Targeted SWCNT Delivery

Single Walled Carbon Nanotubes As Drug Delivery Vehicles: Targeting Doxorubicin to Tumors.

Nanodelivery System of Traditional Chinese Medicine Bioactive Compounds: Application in the Treatment of Prostate Cancer

Covalently Combining Carbon Nanotubes with Anticancer Agent: Preparation and Antitumor Activity

Anti-tumor Response with Immunologically Modified Carbon Nanotubes and Phototherapy

Dual drug-loaded nano-platform for targeted cancer therapy: toward clinical therapeutic efficacy of multifunctionality

Ligand-conjugated multiwalled carbon nanotubes for cancer targeted drug delivery

Advances in Research on Carbon Nanotubes As Therapeutic Drug Delivery Carrier for Tumor Treatment